|Last Price||Today's Change||52-Week Range||Trading Volume|
|3.43 CAD||0.03 (+0.88%)||3.13 - 7.00||100.0 (Below Avg)|
Market data as of 9:38AM 12/01/15. Quotes are delayed by at least 15 min.
Aurinia Pharmaceuticals Announces Outcome from Data and Safety Monitoring Board for Its Phase 2b Study in Lupus Nephritis – Study to Continue as Planned
Business Wire - Tuesday 11/24/2015 8:30 AM ET
Aurinia Reports Third Quarter 2015 Financial Results
Business Wire - Friday 11/13/2015 4:15 PM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.